<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC1718_S10_CH00FM</title>
		<link href="BCSC1718_S10_CH00FM-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC1718_S10_CH00FM" lang="en-US">
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer000" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC1718_S10_CH00FM-web-resources/image/AAO_med_full_clr_c_cmyk.png" alt="" />
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC1718_S10_CH00FM-web-resources/image/AAO_tag_gray_c_cmyk.png" alt="" />
			</div>
		</div>
		<div id="_idContainer002" class="Basic-Text-Frame">
			<p class="NEW-Title"><span class="CharOverride-1">Glaucoma</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer003" class="Basic-Graphics-Frame _idGenObjectStyleOverride-2">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer004" class="Basic-Graphics-Frame _idGenObjectStyleOverride-2">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer005" class="Basic-Graphics-Frame _idGenObjectStyleOverride-2">
			</div>
		</div>
		<div id="_idContainer006" class="Basic-Text-Frame">
			<p class="fm-tp--pub-rev-date-">Last major revision 2016–2017</p>
		</div>
		<div id="_idContainer007" class="Basic-Graphics-Frame _idGenObjectStyleOverride-1">
			<p class="BCSC-Spelled-Out---Cover ParaOverride-1"><span class="CharOverride-2"> </span><span class="CharOverride-2">BCSC</span></p>
			<p class="BCSC-Spelled-Out---Cover"><span class="CharOverride-3"> </span><span class="CharOverride-3">Basic and Clinical</span></p>
			<p class="BCSC-Spelled-Out---Cover"><span class="CharOverride-3"> </span><span class="CharOverride-3">Science Course</span><span class="CharOverride-4">™</span></p>
		</div>
		<div id="_idContainer008" class="Basic-Graphics-Frame _idGenObjectStyleOverride-1">
			<p class="BCSC-Spelled-Out---Cover ParaOverride-1"><span class="CharOverride-2"> </span><span class="CharOverride-2">BCSC</span></p>
			<p class="BCSC-Spelled-Out---Cover"><span class="CharOverride-3"> </span><span class="CharOverride-3">Basic and Clinical</span></p>
			<p class="BCSC-Spelled-Out---Cover"><span class="CharOverride-3"> </span><span class="CharOverride-3">Science Course</span><span class="CharOverride-4">™</span></p>
		</div>
		<div id="_idContainer009" class="Basic-Text-Frame">
			<p class="Year---Cover ParaOverride-2"><span class="CharOverride-5">2017–2018</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer010" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="data:image/jpg;base64,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" alt="" />
			</div>
		</div>
		<div id="_idContainer011" class="Basic-Text-Frame">
			<p class="Basic-Paragraph ParaOverride-3"><span class="CharOverride-6">10</span></p>
		</div>
		<div id="_idContainer012" class="Basic-Text-Frame">
			<p class="fm-tp--pub-rev-date-"><span class="CharOverride-7">Published after collaborative <br />review with the European Board <br />of Ophthalmology subcommittee</span></p>
		</div>
		<div id="_idContainer013" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-copyright-cme-text ParaOverride-4">The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.</p>
			<p class="fm-only_fm-copyright-cme-text ParaOverride-5">The American Academy of Ophthalmology designates this enduring material for a maximum of 10 <span class="CharOverride-8">AMA PRA Category 1 Credits</span><span class="CharOverride-9">™</span>. Physicians should claim only the credit commensurate with the extent of their participation in the activity.</p>
			<p class="fm-only_fm-copyright-text">CME expiration date: June 1, 2019. <span class="CharOverride-8">AMA PRA Category 1 Credits</span><span class="CharOverride-9">™</span> may be claimed only once between June 1, 2016, and the expiration date.</p>
			<p class="fm-only_fm-copyright-text">BCSC<span class="CharOverride-9">®</span> volumes are designed to increase the physician’s ophthalmic knowledge through study and review. Users of this activity are encouraged to read the text and then answer the study questions provided at the back of the book.</p>
			<p class="fm-only_fm-copyright-text">To claim <span class="CharOverride-8">AMA PRA Category 1 Credits</span><span class="CharOverride-9">™</span> upon completion of this activity, learners must demonstrate appropriate knowledge and participation in the activity by taking the posttest for Section 10 and achieving a score of 80% or higher. For further details, please see the instructions for requesting CME credit at the back of the book.</p>
			<p class="fm-only_fm-copyright-text">The Academy provides this material for educational purposes only. It is not intended to represent the only or best method or procedure in every case, nor to replace a physician’s own judgment or give specific advice for case management. Including all indications, contraindications, side effects, and alternative agents for each drug or treatment is beyond the scope of this material. All information and recommendations should be verified, prior to use, with current information included in the manufacturers’ package inserts or other independent sources, and considered in light of the patient’s condition and history. Reference to certain drugs, instruments, and other products in this course is made for illustrative purposes only and is not intended to constitute an endorsement of such. Some material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. <span class="CharOverride-10">The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate, informed patient consent in compliance with applicable law.</span> The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise from the use of any recommendations or other information contained herein.</p>
			<p class="fm-only_fm-copyright-text">AAO, AAOE, American Academy of Ophthalmology, Basic and Clinical Science Course, BCSC, EyeCare America, EyeNet, EyeSmart, EyeWiki, Focal Points, IRIS, ISRS, OKAP, ONE, Ophthalmic Technology Assessments, <span class="italic">Ophthalmology,</span> Preferred Practice Pattern, ProVision, SmartSight, The Ophthalmic News &amp; Education Network, and the AAO logo (shown on cover) and tagline (Protecting Sight. Empowering Lives.) are, among other marks, the registered trademarks and trademarks of the American Academy of Ophthalmology.</p>
			<p class="fm-only_fm-copyright-text ParaOverride-6"><span class="CharOverride-11">Cover image: From BCSC Section 5, </span><span class="italic">Neuro-Ophthalmology.</span><span class="CharOverride-11"> Fundus photograph showing an arteriovenous malformation (racemose angioma) of the retina in a patient with Wyburn-Mason syndrome. </span><span class="italic">(Courtesy of Mark J. Greenwald, MD.)</span></p>
		</div>
		<div id="_idContainer014" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-copyright1--pub-info-">Copyright © 2017 American Academy of Ophthalmology. All rights reserved. No part of this publication may be reproduced without written permission. </p>
			<p class="fm-only_fm-copyright1--pub-info-">Printed in the United States of America.</p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer015" class="_idGenObjectStyleOverride-3">
			</div>
		</div>
		<div id="_idContainer018" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-title _idGenParaOverride-1">Basic and Clinical Science Course</p>
			<p class="fm-only_fm-contributors-text">Louis B. Cantor, MD, Indianapolis, Indiana, <span class="CharOverride-8">Senior Secretary for Clinical Education</span></p>
			<p class="fm-only_fm-contributors-text">Christopher J. Rapuano, MD, Philadelphia, Pennsylvania, <span class="CharOverride-8">Secretary for Lifelong Learning and Assessment</span></p>
			<p class="fm-only_fm-contributors-text">George A. Cioffi, MD, New York, New York,<span class="CharOverride-8"> BCSC Course Chair</span></p>
			<p class="fm-only_fm-h1">Section 10</p>
			<p class="fm-only_fm-h2 ParaOverride-7">Faculty</p>
			<p class="fm-only_fm-contributors-text">Christopher A. Girkin, MD, <span class="italic">Chair,</span> Birmingham, Alabama</p>
			<p class="fm-only_fm-contributors-text">Anjali M. Bhorade, MD, St Louis, Missouri</p>
			<p class="fm-only_fm-contributors-text">JoAnn A. Giaconi, MD, Los Angeles, California</p>
			<p class="fm-only_fm-contributors-text">Felipe A. Medeiros, MD, PhD, San Diego, California</p>
			<p class="fm-only_fm-contributors-text">Arthur J. Sit, MD, Rochester, Minnesota</p>
			<p class="fm-only_fm-contributors-text">Angelo P. Tanna, MD, Chicago, Illinois </p>
			<p class="fm-only_fm-contributors-text">Jonathan G. Crowston, MBBS, PhD, <span class="italic">Consultant,</span> East Melbourne, Victoria, Australia </p>
			<p class="fm-only_fm-disclaimers">The Academy wishes to acknowledge the <span class="italic">American Glaucoma Society</span> for recommending faculty members to the BCSC Section 10 committee. </p>
			<p class="fm-only_fm-disclaimers">The Academy also wishes to acknowledge the following committees for review of this edition:</p>
			<p class="fm-only_fm-disclaimers"><span class="CharOverride-8">Committee on Aging: </span>Thomas A. Graul, MD, Lincoln, Nebraska</p>
			<p class="fm-only_fm-disclaimers"><span class="CharOverride-8">Vision Rehabilitation Committee:</span> Paul I. Homer, MD, Boca Raton, Florida</p>
			<p class="fm-only_fm-disclaimers ParaOverride-8"><span class="CharOverride-8">Practicing Ophthalmologists Advisory Committee for Education:</span> James A. Savage, MD, <span class="italic">Primary Reviewer,</span> Memphis, Tennessee; Edward K. Isbey III, MD, <span class="italic">Chair,</span> Asheville, North Carolina; Alice Bashinsky, MD, Asheville, North Carolina; David Browning, MD, PhD, Charlotte, North Carolina; Bradley Fouraker, MD, Tampa, Florida; Dasa Gangadhar, MD, Wichita, Kansas; Steven J. Grosser, MD, Golden Valley, Minnesota; Stephen R. Klapper, MD, Carmel, Indiana</p>
			<p class="fm-only_fm-disclaimers ParaOverride-9"><img class="_idGenObjectAttribute-2" src="data:image/jpg;base64,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" alt="" /></p>
			<p class="fm-only_fm-disclaimers ParaOverride-10"><span class="CharOverride-8">European Board of Ophthalmology: </span>Carlo Traverso, MD, <span class="italic">Chair,</span> Genoa, Italy; Gordana Sunaric Mégevand, MD, FMH, FEBO, <span class="italic">Liaison,</span> Geneva, Switzerland; Augusto Azuara-Blanco, PhD, FRCS(Ed), FRCOphth, Belfast, Northern Ireland; Anders Heijl, MD, PhD, Malmö, Sweden; Gabor Hollo, MD, PhD, DSc, Budapest, Hungary; Anja Tuulonen, MD, PhD, Tampere, Finland</p>
			<p class="fm-only_fm-h2">Financial Disclosures</p>
			<p class="fm-only_fm-disclaimers ParaOverride-10">Academy staff members who contributed to the development of this product state that within the 12 months prior to their contributions to this CME activity and for the duration of development, they have had no financial interest in or other relationship with any entity discussed in this course that produces, markets, resells, or distributes ophthalmic health care goods or services consumed by or used in patients, or with any competing commercial product or service.</p>
			<p class="fm-only_fm-disclaimers">The authors and reviewers state that within the 12 months prior to their contributions to this CME activity and for the duration of development, they have had the following financial relationships:<span class="CharOverride-12">*</span></p>
			<p class="fm-only_fm-disclaimers">Dr Browning: Aerpio Therapeutics (S), Alimera Sciences (C), Genentech (S), Novartis Pharmaceuticals (S), Pfizer (S), Regeneron Pharmaceuticals (S)</p>
			<p class="fm-only_fm-disclaimers">Dr Crowston: Alcon Laboratories (C, L), Allergan (C, L), Merck &amp; Co (C, L), Pfizer (C, L), Polyactiva (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Fouraker: Addition Technology (C, L), Alcon Laboratories (C, L), KeraVision (C, L), OASIS Medical (C, L) </p>
			<p class="fm-only_fm-disclaimers">Dr Giaconi: Allergan (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Girkin: Carl Zeiss Meditec (S), Heidelberg Engineering (S), SOLX (S)</p>
			<p class="fm-only_fm-disclaimers">Dr Grosser: Ivantis (O)</p>
			<p class="fm-only_fm-disclaimers">Dr Heijl: Allergan (C, L), Santen (L), Zeiss (C, L, P)</p>
			<p class="fm-only_fm-disclaimers">Dr Hollo: Alcon (C, L), Allergan (L), Santen (C, L)</p>
			<p class="fm-only_fm-disclaimers">Dr Isbey: Alcon Laboratories (S), Bausch + Lomb (S)</p>
			<p class="fm-only_fm-disclaimers">Dr Medeiros: Alcon Laboratories (C, S), Allergan (C, S), Carl Zeiss Meditec (S), Heidelberg Engineering (S), Merck &amp; Co (S), Reichert Technologies (S), Topcon (S)</p>
			<p class="fm-only_fm-disclaimers">Dr Savage: Allergan (L)</p>
			<p class="fm-only_fm-disclaimers">Dr Sit: AcuMEMS (C), Aerie Pharmaceuticals (S), Allergan (C), Glaukos Corporation (S), Sensimed AG (C), Sucampo Pharma Americas (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Sunaric Mégevand: Alcon (C), Allergan (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Tanna: Aeon Astron B.V. (C), Alcon Laboratories (C, L), Apotex (C), Merck &amp; Co (L), Sandoz (C), Sucampo Pharmaceuticals (C), Watson Laboratories (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Traverso: Alcon (C, L), Allergan (C), Santen (C, L), Théa (C)</p>
			<p class="fm-only_fm-disclaimers">The other authors and reviewers state that within the 12 months prior to their contributions to this CME activity and for the duration of development, they have had no financial interest in or other relationship with any entity discussed in this course that produces, markets, resells, or distributes ophthalmic health care goods or services consumed by or used in patients, or with any competing commercial product or service.</p>
			<p class="fm-only_fm-h2 ParaOverride-11">Recent Past Faculty</p>
			<p class="fm-only_fm-contributors-text">Keith Barton, MD</p>
			<p class="fm-only_fm-contributors-text">George A. Cioffi, MD</p>
			<p class="fm-only_fm-contributors-text">F. Jane Durcan, MD</p>
			<p class="fm-only_fm-contributors-text">Neeru Gupta, MD, PhD</p>
			<p class="fm-only_fm-contributors-text">Jody R. Piltz-Seymour, MD</p>
			<p class="fm-only_fm-contributors-text">Thomas W. Samuelson, MD</p>
			<p class="fm-only_fm-disclaimers">In addition, the Academy gratefully acknowledges the contributions of numerous past faculty and advisory committee members who have played an important role in the development of previous editions of the Basic and Clinical Science Course.</p>
			<p class="fm-only_fm-h2">American Academy of Ophthalmology Staff</p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-12"><span class="CharOverride-11">Dale E. Fajardo, </span><span class="CharOverride-8">Vice President, Education</span></p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-12"><span class="CharOverride-11">Beth Wilson, </span><span class="CharOverride-8">Director, Continuing Professional Development</span></p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-12"><span class="CharOverride-11">Ann McGuire, </span><span class="CharOverride-8">Acquisitions and Development Manager</span></p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-12"><span class="CharOverride-11">Stephanie Tanaka, </span><span class="CharOverride-8">Publications Manager</span></p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-12"><span class="CharOverride-11">D. Jean Ray, </span><span class="CharOverride-8">Production Manager</span></p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-13"><span class="CharOverride-11">Kimberly Torgerson, </span><span class="CharOverride-8">Publications Editor</span></p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-12"><span class="CharOverride-11">Beth Collins, </span><span class="CharOverride-8">Medical Editor</span></p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-14"><span class="CharOverride-11">Naomi Ruiz, </span><span class="CharOverride-8">Editorial Assistant</span></p>
			<p class="fm-only_fm-title _idGenParaOverride-1">General Introduction</p>
			<p class="body-text--no-indent-">The Basic and Clinical Science Course (BCSC) is designed to meet the needs of residents and practitioners for a comprehensive yet concise curriculum of the field of ophthalmology. The BCSC has developed from its original brief outline format, which relied heavily on outside readings, to a more convenient and educationally useful self-contained text. The Academy updates and revises the course annually, with the goals of integrating the basic science and clinical practice of ophthalmology and of keeping ophthalmologists current with new developments in the various subspecialties.</p>
			<p class="body-text">The BCSC incorporates the effort and expertise of more than 90 ophthalmologists, organized into 13 Section faculties, working with Academy editorial staff. In addition, the course continues to benefit from many lasting contributions made by the faculties of previous editions. Members of the Academy Practicing Ophthalmologists Advisory Committee for Education, Committee on Aging, and Vision Rehabilitation Committee review every volume before major revisions. Members of the European Board of Ophthalmology, organized into Section faculties, also review each volume before major revisions, focusing primarily on differences between American and European ophthalmology practice.</p>
			<p class="fm-only_fm-h2">Organization of the Course</p>
			<p class="body-text--no-indent-">The Basic and Clinical Science Course comprises 13 volumes, incorporating fundamental ophthalmic knowledge, subspecialty areas, and special topics:</p>
			<p class="fm-only_fm-numbered-list-first">&#9;1&#9;Update on General Medicine</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;2&#9;Fundamentals and Principles of Ophthalmology</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;3&#9;Clinical Optics</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;4&#9;Ophthalmic Pathology and Intraocular Tumors</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;5&#9;Neuro-Ophthalmology</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;6&#9;Pediatric Ophthalmology and Strabismus</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;7&#9;Orbit, Eyelids, and Lacrimal System</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;8&#9;External Disease and Cornea</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;9&#9;Intraocular Inflammation and Uveitis</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;10&#9;Glaucoma</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;11&#9;Lens and Cataract</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;12&#9;Retina and Vitreous</p>
			<p class="fm-only_fm-numbered-list-last">&#9;13&#9;Refractive Surgery</p>
			<p class="body-text--no-indent-">In addition, a comprehensive Master Index allows the reader to easily locate subjects throughout the entire series.</p>
			<p class="fm-only_fm-h2">References</p>
			<p class="body-text--no-indent-">Readers who wish to explore specific topics in greater detail may consult the references cited within each chapter and listed in the Basic Texts section at the back of the book. These references are intended to be selective rather than exhaustive, chosen by the BCSC faculty as being important, current, and readily available to residents and practitioners.</p>
			<p class="fm-only_fm-h2">Videos</p>
			<p class="body-text--no-indent-">This edition of Section 10, <span class="italic">Glaucoma,</span> includes videos related to topics covered in the book. The videos were selected by members of the BCSC faculty and are available to readers of the print and electronic versions of Section 10 (www.aao.org/bcscvideo_section10). Mobile-&#173;device users can scan the QR code below (a QR-code reader must already be installed on the device) to access the video content.</p>
			<p class="body-text--no-indent- ParaOverride-15"><img class="_idGenObjectAttribute-3" src="BCSC1718_S10_CH00FM-web-resources/image/QR_BCSC16_S10_videopage.jpg" alt="" /></p>
			<p class="fm-only_fm-h2">Study Questions and CME Credit</p>
			<p class="body-text--no-indent-">Each volume of the BCSC is designed as an independent study activity for ophthalmology residents and practitioners. The learning objectives for this volume are given on page 1. The text, illustrations, and references provide the information necessary to achieve the objectives; the study questions allow readers to test their understanding of the material and their mastery of the objectives. Physicians who wish to claim CME credit for this educational activity may do so by following the instructions given at the end of the book.</p>
			<p class="fm-only_fm-h2">Conclusion</p>
			<p class="body-text--no-indent-">The Basic and Clinical Science Course has expanded greatly over the years, with the addition of much new text, numerous illustrations, and video content. Recent editions have sought to place greater emphasis on clinical applicability while maintaining a solid foundation in basic science. As with any educational program, it reflects the experience of its authors. As its faculties change and medicine progresses, new viewpoints emerge on controversial subjects and techniques. Not all alternate approaches can be included in this series; as with any educational endeavor, the learner should seek additional sources, including Academy Preferred Practice Pattern Guidelines.</p>
			<p class="body-text">The BCSC faculty and staff continually strive to improve the educational usefulness of the course; you, the reader, can contribute to this ongoing process. If you have any suggestions or questions about the series, please do not hesitate to contact the faculty or the editors.</p>
			<p class="body-text">The authors, editors, and reviewers hope that your study of the BCSC will be of lasting value and that each Section will serve as a practical resource for quality patient care.</p>
		</div>
		<div id="_idContainer019" class="Basic-Text-Frame">
			<p class="fm-only_fm-disclaimers-footnote"><span class="CharOverride-13">*</span>C = consultant fees, paid advisory boards, or fees for attending a meeting; L = lecture fees (honoraria), travel fees, or reimbursements when speaking at the invitation of a commercial sponsor; O = equity ownership/&#173;stock options of publicly or privately traded firms (excluding mutual funds) with manufacturers of commercial ophthalmic products or commercial ophthalmic services; P = patents and/or royalties that might be viewed as creating a potential conflict of interest; S = grant support for the past year (all sources) and all sources used for a specific talk or manuscript with no time limitation</p>
		</div>
		<div id="_idContainer020" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-16">American Academy of Ophthalmology</p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-16">655 Beach Street</p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-16">Box 7424</p>
			<p class="fm-only_fm-copyright2--pub-info- ParaOverride-16">San Francisco, CA 94120-7424</p>
		</div>
		<div id="_idContainer021" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-title _idGenParaOverride-1">Contents</p>
			<p class="fm-only_fm-toc-fm1">General Introduction&#9;xiii</p>
			<p class="fm-only_fm-toc-fm2">Objectives<span class="fm-toc--leader-dots-">&#9;</span>1</p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">1</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Introduction to Glaucoma: Terminology, <br />Epidemiology, and&#160;Heredity<span class="fm-toc--leader-dots-">&#9;</span>3</a></p>
			<p class="fm-only_fm-toc03"><a href="">Definitions<span class="fm-toc--leader-dots-">&#9;</span>3</a></p>
			<p class="fm-only_fm-toc04"><a href="">Open-&#173;Angle, Angle-&#173;Closure, Primary, and Secondary Glaucomas<span class="fm-toc--leader-dots-">&#9;</span>3</a></p>
			<p class="fm-only_fm-toc04"><a href="">Combined-Mechanism Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>7</a></p>
			<p class="fm-only_fm-toc03"><a href="">Epidemiologic Aspects of Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>7</a></p>
			<p class="fm-only_fm-toc04"><a href="">Primary Open-&#173;Angle Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>7</a></p>
			<p class="fm-only_fm-toc04"><a href="">Primary Angle-&#173;Closure Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>9</a></p>
			<p class="fm-only_fm-toc03"><a href="">Genetics, Environmental Factors, and Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>10</a></p>
			<p class="fm-only_fm-toc04"><a href="">Environmental Factors<span class="fm-toc--leader-dots-">&#9;</span>10</a></p>
			<p class="fm-only_fm-toc04"><a href="">Genetic Testing<span class="fm-toc--leader-dots-">&#9;</span>11</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">2</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Intraocular Pressure and Aqueous Humor <br />Dynamics<span class="fm-toc--leader-dots-">&#9;</span>13</a></p>
			<p class="fm-only_fm-toc03"><a href="">Aqueous Humor Production and Composition<span class="fm-toc--leader-dots-">&#9;</span>13</a></p>
			<p class="fm-only_fm-toc04"><a href="">Suppression of Aqueous Formation<span class="fm-toc--leader-dots-">&#9;</span>16</a></p>
			<p class="fm-only_fm-toc04"><a href="">Measurement of Aqueous Formation<span class="fm-toc--leader-dots-">&#9;</span>17</a></p>
			<p class="fm-only_fm-toc03"><a href="">Aqueous Humor Outflow<span class="fm-toc--leader-dots-">&#9;</span>17</a></p>
			<p class="fm-only_fm-toc04"><a href="">Trabecular Outflow<span class="fm-toc--leader-dots-">&#9;</span>17</a></p>
			<p class="fm-only_fm-toc04"><a href="">Measurement of Outflow Facility<span class="fm-toc--leader-dots-">&#9;</span>19</a></p>
			<p class="fm-only_fm-toc04"><a href="">Uveoscleral Outflow<span class="fm-toc--leader-dots-">&#9;</span>19</a></p>
			<p class="fm-only_fm-toc03"><a href="">Episcleral Venous Pressure<span class="fm-toc--leader-dots-">&#9;</span>19</a></p>
			<p class="fm-only_fm-toc03"><a href="">Intraocular Pressure<span class="fm-toc--leader-dots-">&#9;</span>20</a></p>
			<p class="fm-only_fm-toc04"><a href="">Distribution in the Population and Relation to Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>20</a></p>
			<p class="fm-only_fm-toc04"><a href="">Factors Influencing Intraocular Pressure<span class="fm-toc--leader-dots-">&#9;</span>21</a></p>
			<p class="fm-only_fm-toc04"><a href="">Clinical Measurement of Intraocular Pressure<span class="fm-toc--leader-dots-">&#9;</span>22</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">3</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Clinical Evaluation<span class="fm-toc--leader-dots-">&#9;</span>29</a></p>
			<p class="fm-only_fm-toc03"><a href="">History and General Examination<span class="fm-toc--leader-dots-">&#9;</span>29</a></p>
			<p class="fm-only_fm-toc04"><a href="">Refraction<span class="fm-toc--leader-dots-">&#9;</span>29</a></p>
			<p class="fm-only_fm-toc04"><a href="">External Adnexae<span class="fm-toc--leader-dots-">&#9;</span>29</a></p>
			<p class="fm-only_fm-toc04"><a href="">Pupils<span class="fm-toc--leader-dots-">&#9;</span>30</a></p>
			<p class="fm-only_fm-toc04"><a href="">Biomicroscopy<span class="fm-toc--leader-dots-">&#9;</span>30</a></p>
			<p class="fm-only_fm-toc03"><a href="">Gonioscopy<span class="fm-toc--leader-dots-">&#9;</span>32</a></p>
			<p class="fm-only_fm-toc04"><a href="">Direct and Indirect Gonioscopy<span class="fm-toc--leader-dots-">&#9;</span>33</a></p>
			<p class="fm-only_fm-toc04"><a href="">Gonioscopic Assessment and Documentation<span class="fm-toc--leader-dots-">&#9;</span>36</a></p>
			<p class="fm-only_fm-toc03"><a href="">The Optic Nerve<span class="fm-toc--leader-dots-">&#9;</span>41</a></p>
			<p class="fm-only_fm-toc04"><a href="">Anatomy and Pathology<span class="fm-toc--leader-dots-">&#9;</span>41</a></p>
			<p class="fm-only_fm-toc03"><a href="">Glaucomatous Optic Neuropathy<span class="fm-toc--leader-dots-">&#9;</span>46</a></p>
			<p class="fm-only_fm-toc04"><a href="">Examination of the Optic Nerve Head<span class="fm-toc--leader-dots-">&#9;</span>48</a></p>
			<p class="fm-only_fm-toc03"><a href="">The Visual Field<span class="fm-toc--leader-dots-">&#9;</span>59</a></p>
			<p class="fm-only_fm-toc04"><a href="">Factors Affecting Perimetry Results<span class="fm-toc--leader-dots-">&#9;</span>59</a></p>
			<p class="fm-only_fm-toc04"><a href="">Automated Static Perimetry<span class="fm-toc--leader-dots-">&#9;</span>60</a></p>
			<p class="fm-only_fm-toc04"><a href="">Interpretation of a Single Visual Field<span class="fm-toc--leader-dots-">&#9;</span>62</a></p>
			<p class="fm-only_fm-toc04"><a href="">Patterns of Visual Field Loss in Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>67</a></p>
			<p class="fm-only_fm-toc04"><a href="">Interpretation of a Series of Visual Fields and Detection <br />of Visual Field Progression<span class="fm-toc--leader-dots-">&#9;</span>71</a></p>
			<p class="fm-only_fm-toc04"><a href="">Other Perimetric Tests<span class="fm-toc--leader-dots-">&#9;</span>75</a></p>
			<p class="fm-only_fm-toc03"><a href="">Other Tests for Selected Patients<span class="fm-toc--leader-dots-">&#9;</span>77</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">4</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Open-&#173;Angle Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>79</a></p>
			<p class="fm-only_fm-toc03"><a href="">Primary Open-&#173;Angle Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>79</a></p>
			<p class="fm-only_fm-toc04"><a href="">Clinical Features<span class="fm-toc--leader-dots-">&#9;</span>79</a></p>
			<p class="fm-only_fm-toc04"><a href="">Risk Factors<span class="fm-toc--leader-dots-">&#9;</span>80</a></p>
			<p class="fm-only_fm-toc04"><a href="">Associated Disorders<span class="fm-toc--leader-dots-">&#9;</span>83</a></p>
			<p class="fm-only_fm-toc04"><a href="">Prognosis and Therapy<span class="fm-toc--leader-dots-">&#9;</span>84</a></p>
			<p class="fm-only_fm-toc03"><a href="">Open-&#173;Angle Glaucoma Without Elevated IOP (Normal-Tension <br />Glaucoma, Low-Tension Glaucoma)<span class="fm-toc--leader-dots-">&#9;</span>85</a></p>
			<p class="fm-only_fm-toc04"><a href="">Risk Factors and Clinical Features<span class="fm-toc--leader-dots-">&#9;</span>85</a></p>
			<p class="fm-only_fm-toc04"><a href="">Differential Diagnosis<span class="fm-toc--leader-dots-">&#9;</span>86</a></p>
			<p class="fm-only_fm-toc04"><a href="">Diagnostic Evaluation<span class="fm-toc--leader-dots-">&#9;</span>87</a></p>
			<p class="fm-only_fm-toc04"><a href="">Prognosis and Therapy<span class="fm-toc--leader-dots-">&#9;</span>87</a></p>
			<p class="fm-only_fm-toc03"><a href="">The Glaucoma Suspect<span class="fm-toc--leader-dots-">&#9;</span>89</a></p>
			<p class="fm-only_fm-toc03"><a href="">Ocular Hypertension<span class="fm-toc--leader-dots-">&#9;</span>89</a></p>
			<p class="fm-only_fm-toc03"><a href="">Secondary Open-&#173;Angle Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>91</a></p>
			<p class="fm-only_fm-toc04"><a href="">Pseudoexfoliation Syndrome<span class="fm-toc--leader-dots-">&#9;</span>91</a></p>
			<p class="fm-only_fm-toc04"><a href="">Pigment Dispersion Syndrome<span class="fm-toc--leader-dots-">&#9;</span>93</a></p>
			<p class="fm-only_fm-toc04"><a href="">Lens-Induced Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>96</a></p>
			<p class="fm-only_fm-toc04"><a href="">Intraocular Tumors<span class="fm-toc--leader-dots-">&#9;</span>98</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ocular Inflammation and Secondary Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>100</a></p>
			<p class="fm-only_fm-toc04"><a href="">Elevated Episcleral Venous Pressure<span class="fm-toc--leader-dots-">&#9;</span>102</a></p>
			<p class="fm-only_fm-toc04"><a href="">Trauma and Surgery<span class="fm-toc--leader-dots-">&#9;</span>103</a></p>
			<p class="fm-only_fm-toc04"><a href="">Schwartz Syndrome (Schwartz-Matsuo Syndrome)<span class="fm-toc--leader-dots-">&#9;</span>109</a></p>
			<p class="fm-only_fm-toc04"><a href="">Drugs and Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>109</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">5</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Angle-&#173;Closure Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>117</a></p>
			<p class="fm-only_fm-toc03"><a href="">Introduction<span class="fm-toc--leader-dots-">&#9;</span>117</a></p>
			<p class="fm-only_fm-toc03"><a href="">Pathogenesis and Pathophysiology of Angle Closure<span class="fm-toc--leader-dots-">&#9;</span>118</a></p>
			<p class="fm-only_fm-toc04"><a href="">Pupillary Block<span class="fm-toc--leader-dots-">&#9;</span>118</a></p>
			<p class="fm-only_fm-toc04"><a href="">Lens-Induced Pupillary Block Angle-&#173;Closure Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>119</a></p>
			<p class="fm-only_fm-toc04"><a href="">Angle Closure Without Pupillary Block<span class="fm-toc--leader-dots-">&#9;</span>119</a></p>
			<p class="fm-only_fm-toc04"><a href="">Iris-Induced Angle Closure<span class="fm-toc--leader-dots-">&#9;</span>120</a></p>
			<p class="fm-only_fm-toc03"><a href="">Primary Angle Closure<span class="fm-toc--leader-dots-">&#9;</span>120</a></p>
			<p class="fm-only_fm-toc04"><a href="">Risk Factors for Developing Primary Angle Closure<span class="fm-toc--leader-dots-">&#9;</span>120</a></p>
			<p class="fm-only_fm-toc04"><a href="">Primary Angle-&#173;Closure Suspect<span class="fm-toc--leader-dots-">&#9;</span>122</a></p>
			<p class="fm-only_fm-toc04"><a href="">Acute Primary Angle Closure<span class="fm-toc--leader-dots-">&#9;</span>123</a></p>
			<p class="fm-only_fm-toc04"><a href="">Subacute or Intermittent Angle Closure<span class="fm-toc--leader-dots-">&#9;</span>125</a></p>
			<p class="fm-only_fm-toc04"><a href="">Chronic Angle Closure<span class="fm-toc--leader-dots-">&#9;</span>126</a></p>
			<p class="fm-only_fm-toc03"><a href="">Plateau Iris Syndrome<span class="fm-toc--leader-dots-">&#9;</span>127</a></p>
			<p class="fm-only_fm-toc03"><a href="">Secondary Angle Closure With Pupillary Block<span class="fm-toc--leader-dots-">&#9;</span>128</a></p>
			<p class="fm-only_fm-toc04"><a href="">Lens-Induced Angle Closure<span class="fm-toc--leader-dots-">&#9;</span>128</a></p>
			<p class="fm-only_fm-toc03"><a href="">Secondary Angle Closure Without Pupillary Block<span class="fm-toc--leader-dots-">&#9;</span>132</a></p>
			<p class="fm-only_fm-toc04"><a href="">Neovascular Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>132</a></p>
			<p class="fm-only_fm-toc04"><a href="">Iridocorneal Endothelial Syndrome<span class="fm-toc--leader-dots-">&#9;</span>136</a></p>
			<p class="fm-only_fm-toc04"><a href="">Tumors<span class="fm-toc--leader-dots-">&#9;</span>138</a></p>
			<p class="fm-only_fm-toc04"><a href="">Inflammation<span class="fm-toc--leader-dots-">&#9;</span>138</a></p>
			<p class="fm-only_fm-toc04"><a href="">Malignant Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>139</a></p>
			<p class="fm-only_fm-toc04"><a href="">Nonrhegmatogenous Retinal Detachment and Uveal Effusions<span class="fm-toc--leader-dots-">&#9;</span>141</a></p>
			<p class="fm-only_fm-toc04"><a href="">Epithelial and Fibrous Ingrowth<span class="fm-toc--leader-dots-">&#9;</span>141</a></p>
			<p class="fm-only_fm-toc04"><a href="">Trauma<span class="fm-toc--leader-dots-">&#9;</span>142</a></p>
			<p class="fm-only_fm-toc04"><a href="">Retinal Surgery and Retinal Vascular Disease<span class="fm-toc--leader-dots-">&#9;</span>143</a></p>
			<p class="fm-only_fm-toc04"><a href="">Nanophthalmos<span class="fm-toc--leader-dots-">&#9;</span>144</a></p>
			<p class="fm-only_fm-toc04"><a href="">Persistent Fetal Vasculature<span class="fm-toc--leader-dots-">&#9;</span>144</a></p>
			<p class="fm-only_fm-toc04"><a href="">Flat Anterior Chamber<span class="fm-toc--leader-dots-">&#9;</span>144</a></p>
			<p class="fm-only_fm-toc04"><a href="">Drug-Induced Secondary Angle-&#173;Closure Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>145</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">6</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Glaucoma in Children and&#160;Adolescents<span class="fm-toc--leader-dots-">&#9;</span>147</a></p>
			<p class="fm-only_fm-toc03"><a href="">Classification<span class="fm-toc--leader-dots-">&#9;</span>147</a></p>
			<p class="fm-only_fm-toc03"><a href="">Genetics<span class="fm-toc--leader-dots-">&#9;</span>150</a></p>
			<p class="fm-only_fm-toc03"><a href="">Primary Congenital Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>151</a></p>
			<p class="fm-only_fm-toc03"><a href="">Juvenile Open-&#173;Angle Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>153</a></p>
			<p class="fm-only_fm-toc03"><a href="">Developmental Glaucomas With Associated Ocular or Systemic&#160;<br />Anomalies<span class="fm-toc--leader-dots-">&#9;</span>153</a></p>
			<p class="fm-only_fm-toc04"><a href="">Axenfeld-Rieger Syndrome<span class="fm-toc--leader-dots-">&#9;</span>153</a></p>
			<p class="fm-only_fm-toc04"><a href="">Peters Anomaly<span class="fm-toc--leader-dots-">&#9;</span>154</a></p>
			<p class="fm-only_fm-toc04"><a href="">Aniridia<span class="fm-toc--leader-dots-">&#9;</span>154</a></p>
			<p class="fm-only_fm-toc04"><a href="">Sturge-Weber Syndrome<span class="fm-toc--leader-dots-">&#9;</span>155</a></p>
			<p class="fm-only_fm-toc04"><a href="">Neurofibromatosis<span class="fm-toc--leader-dots-">&#9;</span>156</a></p>
			<p class="fm-only_fm-toc03"><a href="">Secondary Glaucomas<span class="fm-toc--leader-dots-">&#9;</span>156</a></p>
			<p class="fm-only_fm-toc04"><a href="">Aphakic Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>156</a></p>
			<p class="fm-only_fm-toc03"><a href="">Evaluating the Pediatric Glaucoma Patient<span class="fm-toc--leader-dots-">&#9;</span>157</a></p>
			<p class="fm-only_fm-toc04"><a href="">History<span class="fm-toc--leader-dots-">&#9;</span>157</a></p>
			<p class="fm-only_fm-toc04"><a href="">Visual Acuity<span class="fm-toc--leader-dots-">&#9;</span>158</a></p>
			<p class="fm-only_fm-toc04"><a href="">External Examination<span class="fm-toc--leader-dots-">&#9;</span>158</a></p>
			<p class="fm-only_fm-toc04"><a href="">Anterior Segment Examination<span class="fm-toc--leader-dots-">&#9;</span>158</a></p>
			<p class="fm-only_fm-toc04"><a href="">Tonometry<span class="fm-toc--leader-dots-">&#9;</span>158</a></p>
			<p class="fm-only_fm-toc04"><a href="">Pachymetry<span class="fm-toc--leader-dots-">&#9;</span>159</a></p>
			<p class="fm-only_fm-toc04"><a href="">Gonioscopy<span class="fm-toc--leader-dots-">&#9;</span>159</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optic Nerve and Fundus Evaluation<span class="fm-toc--leader-dots-">&#9;</span>160</a></p>
			<p class="fm-only_fm-toc04"><a href="">A-Scan Ultrasonography<span class="fm-toc--leader-dots-">&#9;</span>160</a></p>
			<p class="fm-only_fm-toc04"><a href="">Other Testing<span class="fm-toc--leader-dots-">&#9;</span>160</a></p>
			<p class="fm-only_fm-toc03"><a href="">Treatment Overview<span class="fm-toc--leader-dots-">&#9;</span>160</a></p>
			<p class="fm-only_fm-toc04"><a href="">Surgical Management<span class="fm-toc--leader-dots-">&#9;</span>160</a></p>
			<p class="fm-only_fm-toc04"><a href="">Medical Management<span class="fm-toc--leader-dots-">&#9;</span>164</a></p>
			<p class="fm-only_fm-toc03"><a href="">Prognosis and Follow-Up<span class="fm-toc--leader-dots-">&#9;</span>166</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">7</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Medical Management of&#160;Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>169</a></p>
			<p class="fm-only_fm-toc03"><a href="">Prostaglandin Analogues<span class="fm-toc--leader-dots-">&#9;</span>170</a></p>
			<p class="fm-only_fm-toc04"><a href="">Mechanism of Action<span class="fm-toc--leader-dots-">&#9;</span>170</a></p>
			<p class="fm-only_fm-toc04"><a href="">Available Agents and Dosing Frequency<span class="fm-toc--leader-dots-">&#9;</span>170</a></p>
			<p class="fm-only_fm-toc04"><a href="">Adverse Effects<span class="fm-toc--leader-dots-">&#9;</span>175</a></p>
			<p class="fm-only_fm-toc03"><a href="">Adrenergic Drugs<span class="fm-toc--leader-dots-">&#9;</span>176</a></p>
			<p class="fm-only_fm-toc04"><a href=""><span class="CharOverride-14">b</span>-Adrenergic Antagonists<span class="fm-toc--leader-dots-">&#9;</span>176</a></p>
			<p class="fm-only_fm-toc04"><a href="">Adrenergic Agonists<span class="fm-toc--leader-dots-">&#9;</span>177</a></p>
			<p class="fm-only_fm-toc03"><a href="">Carbonic Anhydrase Inhibitors<span class="fm-toc--leader-dots-">&#9;</span>179</a></p>
			<p class="fm-only_fm-toc04"><a href="">Mechanism of Action<span class="fm-toc--leader-dots-">&#9;</span>179</a></p>
			<p class="fm-only_fm-toc04"><a href="">Available Agents and Dosing Frequency<span class="fm-toc--leader-dots-">&#9;</span>179</a></p>
			<p class="fm-only_fm-toc04"><a href="">Adverse Effects and Contraindications<span class="fm-toc--leader-dots-">&#9;</span>180</a></p>
			<p class="fm-only_fm-toc03"><a href="">Parasympathomimetic Agents<span class="fm-toc--leader-dots-">&#9;</span>181</a></p>
			<p class="fm-only_fm-toc04"><a href="">Mechanism of Action<span class="fm-toc--leader-dots-">&#9;</span>181</a></p>
			<p class="fm-only_fm-toc04"><a href="">Adverse Effects<span class="fm-toc--leader-dots-">&#9;</span>181</a></p>
			<p class="fm-only_fm-toc03"><a href="">Combined Medications<span class="fm-toc--leader-dots-">&#9;</span>182</a></p>
			<p class="fm-only_fm-toc03"><a href="">Hyperosmotic Agents<span class="fm-toc--leader-dots-">&#9;</span>182</a></p>
			<p class="fm-only_fm-toc03"><a href="">General Approach to Medical Treatment<span class="fm-toc--leader-dots-">&#9;</span>183</a></p>
			<p class="fm-only_fm-toc04"><a href="">Long-Term Therapy<span class="fm-toc--leader-dots-">&#9;</span>183</a></p>
			<p class="fm-only_fm-toc04"><a href="">Therapy for Acute Intraocular Pressure Elevation<span class="fm-toc--leader-dots-">&#9;</span>184</a></p>
			<p class="fm-only_fm-toc04"><a href="">Administration of Ocular Medications<span class="fm-toc--leader-dots-">&#9;</span>184</a></p>
			<p class="fm-only_fm-toc04"><a href="">Use of Glaucoma Medications During Pregnancy or by <br />Breastfeeding Mothers<span class="fm-toc--leader-dots-">&#9;</span>185</a></p>
			<p class="fm-only_fm-toc04"><a href="">Use of Glaucoma Medications in Elderly Patients<span class="fm-toc--leader-dots-">&#9;</span>186</a></p>
			<p class="fm-only_fm-toc04"><a href="">Generic Medications<span class="fm-toc--leader-dots-">&#9;</span>186</a></p>
			<p class="fm-only_fm-toc04"><a href="">Patient Adherence to a Medication Regimen<span class="fm-toc--leader-dots-">&#9;</span>186</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">8</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Surgical Therapy for Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>187</a></p>
			<p class="fm-only_fm-toc03"><a href="">Laser Surgery<span class="fm-toc--leader-dots-">&#9;</span>188</a></p>
			<p class="fm-only_fm-toc04"><a href="">Laser Trabeculoplasty<span class="fm-toc--leader-dots-">&#9;</span>188</a></p>
			<p class="fm-only_fm-toc04"><a href="">Laser Iridotomy<span class="fm-toc--leader-dots-">&#9;</span>191</a></p>
			<p class="fm-only_fm-toc04"><a href="">Laser Gonioplasty, or Peripheral Iridoplasty<span class="fm-toc--leader-dots-">&#9;</span>193</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cyclodestruction<span class="fm-toc--leader-dots-">&#9;</span>194</a></p>
			<p class="fm-only_fm-toc03"><a href="">Incisional Surgery<span class="fm-toc--leader-dots-">&#9;</span>196</a></p>
			<p class="fm-only_fm-toc04"><a href="">Trabeculectomy<span class="fm-toc--leader-dots-">&#9;</span>197</a></p>
			<p class="fm-only_fm-toc04"><a href="">Combined Cataract and Trabeculectomy<span class="fm-toc--leader-dots-">&#9;</span>211</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cataract Extraction<span class="fm-toc--leader-dots-">&#9;</span>213</a></p>
			<p class="fm-only_fm-toc04"><a href="">Tube Shunt Implantation<span class="fm-toc--leader-dots-">&#9;</span>213</a></p>
			<p class="fm-only_fm-toc04"><a href="">Nonpenetrating Glaucoma Surgery<span class="fm-toc--leader-dots-">&#9;</span>217</a></p>
			<p class="fm-only_fm-toc04"><a href="">Other Glaucoma Surgeries<span class="fm-toc--leader-dots-">&#9;</span>219</a></p>
			<p class="fm-only_fm-toc04"><a href="">Incisional Surgeries Specific to Angle-&#173;Closure Glaucoma<span class="fm-toc--leader-dots-">&#9;</span>220</a></p>
			<p class="fm-only_fm-toc03"><a href="">Special Considerations in the Surgical Management of&#160;Elderly<br />Patients<span class="fm-toc--leader-dots-">&#9;</span>221</a></p>
			<p class="fm-only_fm-toc-endmatter-first">Basic Texts&#9;223</p>
			<p class="fm-only_fm-toc03">Related Academy Materials&#9;225</p>
			<p class="fm-only_fm-toc03">Requesting Continuing Medical Education Credit&#9;227</p>
			<p class="fm-only_fm-toc03">Study Questions&#9;229</p>
			<p class="fm-only_fm-toc03">Answer Sheet for Section 10 Study Questions&#9;235</p>
			<p class="fm-only_fm-toc03">Answers&#9;237</p>
			<p class="fm-only_fm-toc03">Index&#9;241</p>
		</div>
		<div id="_idContainer022" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhv"> <span class="rh-bullet"></span> Contents</p>
		</div>
		<div id="_idContainer023" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhr">Contents <span class="rh-bullet">d</span>  </p>
		</div>
		<div id="_idContainer024" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhv"> <span class="rh-bullet"></span> Contents</p>
		</div>
		<div id="_idContainer025" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhv"> <span class="rh-bullet"></span> General Introduction</p>
		</div>
	</body>
</html>
